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454a Tuesday, March 8, 2011between 40-150 pN (500 nm/s pulling speed) which were evident as ‘‘saw
tooth’’ peaks in force spectra. Spectra with up to 11 peaks were obtained.
The curves also revealed region(s) of very low stability that could be stretched
>100 nm prior to any unfolding event. In force extension curves of a shorter
three domain construct comprised only of the M-domain and its two flanking
Ig domains (i.e., C1-M-C2) an extensible region with a contour length of
435 4 nm and persistence length of 0.425 0.1 nm was also observed before
domain unfolding in no more than two sawtooth peaks. The latter data suggest
that the M-domain contributes to the extensible segment of cMyBP-C and that
the M-domain exhibits mechanical properties that are distinct from those of Ig
or Fn-like domains. The M-domain may thus function as a spring-like element
within cMyBP-C. Supported by NIH HL080367.
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N-Terminal Fragment of Cardiac Myosin Binding Protein-C (CMYBP-C)
Reduces Actomyosin Power Output in the Laser Trap Assay
Abbey Weith, James Gulick, Peter VanBuren, Jeffrey Robbins,
David M. Warshaw.
Mutations in cMyBP-C cause hypertrophic cardiomyopathy, but cMyBP-C’s
modulation of cardiac contractility is poorly understood. The N-terminus of
cMyBP-C binds actin and myosin S2, while the C-terminus binds the myosin
rod. Thus, cMyBP-C may act as a tether between the thick and thin filament,
imposing a load against which myosin must operate. We used a laser trap force
clamp assay (Debold et al. B.J., 2005) to characterize actomyosin’s force veloc-
ity relationship (F:V) in the absence and presence of a bacterially expressed N-
terminal cMyBP-C fragment, C0C3. In this assay a small ensemble of skeletal
myosin (~8 heads) translocates a skeletal actin filament under a series of con-
stant loads (1-8 pN), resulting in a classic hyperbolic F:V with a maximum iso-
metric force of 10 5 2 pN. Adding C0C3 at a 1:1 ratio to myosin depressed
actomyosin’s F:V: i.e. 48% reduction in maximum unloaded velocity with
no effect on maximum force. This reduced actomyosin’s maximum power out-
put by 40%. The depressed velocities suggest C0C3 may impose as much as 2
pN of opposing load to the myosin ensemble. As limited numbers of myosin
translocate the actin filament under load, a finite probability exists that no my-
osin will be attached, causing rapid (~2 ms duration) backward movements (34
5 1 nm) of the actin filament, i.e. slips. The frequency of slips rises with in-
creasing load, which is diminished significantly in the presence of C0C3, sug-
gesting C0C3 prevents slips by its attachment to the actin filament. Based on
the depression of the F:V and fewer actin filament slips in the presence of
C0C3, we propose that the N-terminus of cMyBP-C can tether actin and impose
an effective viscous load in the sarcomere to modulate cardiac power output.
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Charged Amino Acids in the N-Terminus of Cardiac Myosin Binding
Protein-C Contribute to Contractile Effects in Permeabilized Myocytes
Kristina L. Bezold, Samantha P. Harris.
Recombinant N-terminal domains of cardiac myosin binding protein C
(cMyBP-C) increase calcium-sensitivity of force (pCa50) and the rate of ten-
sion redevelopement (ktr) in permeabilized cardiac myocytes. To identify spe-
cific amino acids required for these effects, we investigated functional effects
of alanine substitution mutations of charged residues near phosphorylation sites
within the regulatory M-domain of cMyBP-C. Mutations were introduced into
a recombinant protein, C1C2, comprised of the M-domain and its two flanking
Ig domains (i.e, C1-M-C2). Compared to wild-type C1C2, a double mutant
containing A for R substitutions at positions 270 and 271 upstream of S273
(phosphorlyation site A), reduced the ability of C1C2 to increase force in per-
meabilized rat cardiac trabeculae. Another double mutant, the 299AA300 substi-
tution for 299KR300 upstream of S302 (phosphorylation site C), also reduced the
efficacy of C1C2. A triple mutant that replaced a cluster of three charged res-
idues 298KKR300 nearly abolished the functional effects of C1C2. These results
suggest that positively charged amino acids upstream of protein kinase A phos-
phorylation sites are important for mediating the contractile effects of C1C2
and that these sites may be involved in the in vivo response to -adrenergic stim-
ulation potentially by contributing to binding of the M-domain to actin and/or
myosin S2. This work is supported by NIH HL080367 to SPH and a DOD
NDSEG fellowship to KLB.
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Uncovering Effects of the Familial Hypertrophic Cardiomyopathy
(fHCM) Related ß-Myosin Mutation Arg723gly in Human Cardiomyo-
cytes
Theresia Kraft, Nicky M. Boontje, Snigdha Tripathi, Antonio Francino,
Francisco Navarro-Lo´pez, Bernhard Brenner, Ger J. Stienen, Jolanda van,
der Velden.
Mutations in sarcomeric proteins have been identified as the major cause of
fHCM. The primary functional effects of these mutations at the sarcomere levelof cardiomyocytes, however, are still largely unknown. To address this point
we studied cardiomyocytes of the left ventricle (LV) from explanted hearts
of two patients with ß-myosin (ß-MHC) mutation R723G (Enjuto et al.,
JMCC 2000).
Our measurements revealed reduced maximum force generation of myocytes
but unchanged calcium-sensitivity. In contrast, previous studies on slow skel-
etal muscle fibers expressing ß-MHC with the same mutation showed reduced
calcium-sensitivity and increased maximum force. To address this discrepancy
we first determined the expression of mutated and wildtype ß-MHC-mRNA in
LV tissue. 6252% of total ß-MHC-mRNA was found to contain the mutation,
just as seen in M. soleus. Secondly, similar to previous findings for failing hu-
man heart, gel electrophoresis of the fHCM cardiac tissue showed reduced
phosphorylation of troponins I (TnI) and T, myosin binding protein C
(MyBP-C), and myosin light chain 2 compared to donor tissue. Adjustment
of phosphorylation of TnI and MyBP-C in donor and HCM myocytes by treat-
ment with protein kinase A (PKA), however, uncovered an originally masked
reduction in calcium-sensitivity while maximum force was not affected by
PKA treatment. Electron microscopy showed reduced myofibrillar density in
cardiac tissue samples of the patients which may account for the reduced force.
In conclusion, our study reveals that secondary, adaptational processes, trig-
gered by the fHCM-related mutation, can obscure primary effects.
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Zipper-Interacting Protein Kinase Phosphorylates Cardiac Myosin
Audrey N. Chang, Guohua Chen, Pavan Battiprolu, Robert D. Gerard,
Cheng-Hai Zhang, Min-Sheng Zhu, Kristine E. Kamm, James T. Stull.
Zipper-interacting protein kinase (ZIPK) or DAPK3, is a member of the death-
associated-protein kinase family associated with apoptosis in nonmuscle cells
where it phosphorylates myosin regulatory light chain (RLC) to promote mem-
brane blebbing. ZIPK mRNA is abundant in muscles, prompting our investiga-
tion of its role in the heart. A substrate search on mouse heart homogenates led
to the discovery that cardiac RLC is a substrate for ZIPK. Enzyme kinetic stud-
ies revealed that both smooth and cardiac RLCs were good substrates, with
a Vmax value two-fold greater for cardiac as compared to smooth/nonmuscle
RLC. Moreover, ZIPK phosphorylated cardiac RLC at Ser15, the site respon-
sible for modulating Ca2þ sensitivity of myofibrillar contraction. Knockdown
of ZIPK in isolated neonatal cardiac myocytes by siRNA decreased the extent
of RLC Ser15 phosphorylation. Localization studies using adenovirus- medi-
ated overexpression of GFP-ZIPK in neonatal and adult rat cardiac myocytes
showed it is in the nucleus, but also the cytoplasm where it may affect RLC
phosphorylation. In adult cardiac myocytes, ZIPK appears to associate with
myofilaments. ZIPK gene ablation specifically in mouse heart (ZKflox/
Nkx2.5Cre) did not affect basal RLC phosphorylation, nor did it induce appar-
ent pathological responses (assessed by histological analysis and heart weight
measurements). Based on what is known about the DAPK family, we hypoth-
esize that ZIPK function in the heart may be stress or death signal-dependent.
Effects of physiological and pathophysiological stresses on hearts from ZKflox/
Nkx2.5Cre mice are currently being investigated. Supported by NIH NHLBI (J.
T. S.) and AHA Postdoctoral Fellowship (A.N.C.).
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Kinetics of Mouse Alpha-Myosin S1 a Fast Myosin
Heresh Rezavandi, Michael A. Geeves.
The fast skeletal muscle myosins and the slow/b-cardiac myosins have been
well described but few kinetic studies of the a cardiac myosin have been pre-
sented. Here we show that the mouse alpha cardiac myosin has more in com-
mon with fast skeletal type myosin than the slower B-type myosin. The data
for individual rate constant for mouse a myosin S1 are compared to our pub-
lished values for the rabbit fast muscle and slow/bmyosin S1. The ADP affinity
for acto.S1 is much weaker (250 mM) than beta-S1 (10 mM) and similar to that
of fast rabbit muscle S1 (120 mM). The rate constant for ADP release is too fast
to measure for mouse a -S1 and rabbit fast muscle S1 but 63 s1 for the rabbit
b-S1. For all myosins affinity of actin form myosin is reduced by ADP and the
affinity of ADP for S1 is reduced by actin. This thermodynamic coupling ratio
is 10 for b-S1 but ~50-100 for fast muscle S1 and a-S1. The ATP hydrolysis
step rate constant estimated from the protein fluorescence changes is 150 s1
similar tor fast muscle S1 (120 s1) and faster that b-S1 (21 s1). These values
suggest that the ADP release from AMD and the hyrdolysis step are changed in
parallel and this is consistent with the hydrolysis step having a role in defining
the lifetime of the detached state (M.ATP) while ADP release controls the
lifetime of the attached state. Thus the duty ratio can remain similar while
the cycle time is altered. All other values assayed show no major difference be-
tween the three isoforms of myosin. Overall despite the greater sequence sim-
ilarity between a and b cardic S1 the a-S1 shares kinetic properties with the fast
muscle S1.
